Application and Assessment of Deep Learning for the Generation of Potential NMDA Receptor Antagonists

by   Katherine J. Schultz, et al.

Uncompetitive antagonists of the N-methyl D-aspartate receptor (NMDAR) have demonstrated therapeutic benefit in the treatment of neurological diseases such as Parkinson's and Alzheimer's, but some also cause dissociative effects that have led to the synthesis of illicit drugs. The ability to generate NMDAR antagonists in silico is therefore desirable both for new medication development and for preempting and identifying new designer drugs. Recently, generative deep learning models have been applied to de novo drug design as a means to expand the amount of chemical space that can be explored for potential drug-like compounds. In this study, we assess the application of a generative model to the NMDAR to achieve two primary objectives: (i) the creation and release of a comprehensive library of experimentally validated NMDAR phencyclidine (PCP) site antagonists to assist the drug discovery community and (ii) an analysis of both the advantages conferred by applying such generative artificial intelligence models to drug design and the current limitations of the approach. We apply, and provide source code for, a variety of ligand- and structure-based assessment techniques used in standard drug discovery analyses to the deep learning-generated compounds. We present twelve candidate antagonists that are not available in existing chemical databases to provide an example of what this type of workflow can achieve, though synthesis and experimental validation of these compounds is still required.


page 5

page 8

page 12

page 18


Structure-based drug discovery with deep learning

Artificial intelligence (AI) in the form of deep learning bears promise ...

DeepScaffold: a comprehensive tool for scaffold-based de novo drug discovery using deep learning

The ultimate goal of drug design is to find novel compounds with desirab...

A Systematic Assessment of Deep Learning Models for Molecule Generation

In recent years the scientific community has devoted much effort in the ...

Structure-Based Networks for Drug Validation

Classifying chemicals according to putative modes of action (MOAs) is of...

An efficient graph generative model for navigating ultra-large combinatorial synthesis libraries

Virtual, make-on-demand chemical libraries have transformed early-stage ...

How Much of the Chemical Space Has Been Explored? Selecting the Right Exploration Measure for Drug Discovery

Forming a molecular candidate set that contains a wide range of potentia...

Network-principled deep generative models for designing drug combinations as graph sets

Combination therapy has shown to improve therapeutic efficacy while redu...

Please sign up or login with your details

Forgot password? Click here to reset